False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications

[1 ]From the Center for Medicine in the Media, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH (S.W.); the Lisa Schwartz Program for Truth in Medicine, Norwich, VT (S.W.); the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (S.W., A.K.); and Yale University, New Haven, CT (N.P.).